Acadian Asset Management’s Crescent Biopharma CBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11	Closed	–	–	1697
2024 Q4	$0	Sell	11 -3,563	-100%	-$97.1K	﹤0.01%	1833
2024 Q3	$59K	Sell	3,574 -1,774	-33%	-$37.2K	﹤0.01%	1749
2024 Q2	$150K	Buy	5,348 +2,043	+62%	+$212K	﹤0.01%	1480
2024 Q1	$991K	Sell	3,305 -2,107	-39%	-$629K	﹤0.01%	842
2023 Q4	$1.27M	Sell	5,412 -3,029	-36%	-$471K	﹤0.01%	791
2023 Q3	$1.26M	Sell	8,441 -3,056	-27%	-$482K	0.01%	808
2023 Q2	$2M	Sell	11,497 -2,520	-18%	-$423K	0.01%	688
2023 Q1	$1.76M	Sell	14,017 -5,414	-28%	-$1.22M	0.01%	740
2022 Q4	$5.89M	Sell	19,431 -470	-2%	-$69.3K	0.03%	401
2022 Q3	$1.1M	Hold	19,901	–	–	0.01%	782
2022 Q2	$1.19M	Hold	19,901	–	–	0.01%	775
2022 Q1	$2.27M	Buy	19,901 +390	+2%	+$45.8K	0.01%	643
2021 Q4	$2.81M	Buy	19,511 +650	+3%	+$118K	0.01%	577
2021 Q3	$4.13M	Sell	18,861 -656	-3%	-$139K	0.02%	498
2021 Q2	$4.53M	Buy	19,517 +3,064	+19%	+$780K	0.02%	490
2021 Q1	$4.95M	Buy	16,453 +8,356	+103%	+$2.99M	0.02%	482
2020 Q4	$3.04M	Buy	8,097 +3,787	+88%	+$1.33M	0.01%	631
2020 Q3	$1.32M	Buy	4,310 +1,651	+62%	+$631K	0.01%	797
2020 Q2	$1M	Buy	2,659 +2,625	+7,721%	+$743K	﹤0.01%	962
2020 Q1	$8K	Hold	34	–	–	﹤0.01%	1714
2019 Q4	$18K	Sell	34 -130	-79%	-$70.4K	﹤0.01%	1729
2019 Q3	$71K	Buy	+164	New	+$105K	﹤0.01%	1557
2016 Q4	–	Sell	-5	Closed	-$4K	–	1681
2016 Q3	$4K	Sell	5 -248	-98%	-$190K	﹤0.01%	1334
2016 Q2	$183K	Buy	253 +232	+1,105%	+$160K	﹤0.01%	946
2016 Q1	$12K	Buy	+21	New	+$10.8K	﹤0.01%	1163
2015 Q3	–	Sell	-17	Closed	-$14K	–	1346
2015 Q2	$14K	Hold	17	–	–	﹤0.01%	1114
2015 Q1	$14K	Buy	+17	New	+$13.2K	﹤0.01%	1150